ALUR vs. QTI, DXR, ICCM, MDAI, TELA, CTSO, NEPH, BDMD, SURG, and SRTS
Should you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include QT Imaging (QTI), Daxor (DXR), IceCure Medical (ICCM), Spectral AI (MDAI), TELA Bio (TELA), Cytosorbents (CTSO), Nephros (NEPH), Baird Medical Investment (BDMD), SurgePays (SURG), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry.
Allurion Technologies vs. Its Competitors
Allurion Technologies (NYSE:ALUR) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.
Allurion Technologies has a beta of -0.45, meaning that its stock price is 145% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, meaning that its stock price is 120% less volatile than the S&P 500.
QT Imaging has a net margin of 0.00% compared to Allurion Technologies' net margin of -158.30%.
Allurion Technologies presently has a consensus target price of $9.25, suggesting a potential upside of 366.94%. Given Allurion Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Allurion Technologies is more favorable than QT Imaging.
21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 9.6% of Allurion Technologies shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, QT Imaging had 1 more articles in the media than Allurion Technologies. MarketBeat recorded 1 mentions for QT Imaging and 0 mentions for Allurion Technologies. QT Imaging's average media sentiment score of 1.42 beat Allurion Technologies' score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media.
QT Imaging has lower revenue, but higher earnings than Allurion Technologies.
Summary
QT Imaging beats Allurion Technologies on 8 of the 13 factors compared between the two stocks.
Get Allurion Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Allurion Technologies Competitors List
Related Companies and Tools
This page (NYSE:ALUR) was last updated on 10/22/2025 by MarketBeat.com Staff